solomo.ai

Abate As Industries Ltd (ABATEAS) — shareholding pattern, promoter holding, financials and share price

About Abate As Industries Ltd (ABATEAS)

Abate As Industries Ltd operates in the Hospital industry, within the Healthcare sector. It trades on the NSE as ABATEAS and on the BSE under scrip code 531658. Its ISIN is INE454E01013.

Incorporated in 1991, Abate As Industries Ltd primarily operates in the eye healthcare segment through its super specialty hospitals and optical outlets [1]

Abate As Industries Ltd, previously Trijal Industries Ltd, is primarily involved in trading goods and providing financial consultancy services.

The company has recently changed its name to Abate As Industries Ltd, establishing a new brand identity and corporate direction.

Listed peers in Hospital: Lotus Eye Hospital & Institute Ltd, Aashka Hospitals Ltd, Fortis Malar Hospitals Ltd, Maitreya Medicare Ltd, Shanmuga Hospital Ltd, Sangani Hospitals Ltd.

Valuation & Returns

10 Jul 2026

At ₹9.98 a share on 10 Jul 2026, Abate As Industries Ltd (ABATEAS) was valued at a price-to-earnings ratio of 12.78x against an industry P/E of 61.73x and a price-to-book of 0.96x on a book value of ₹10.39 per share as of Mar 2025. Solomo computes return on equity of 7.52% and return on capital employed of 7.79% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.

P/E
12.78x
Industry P/E
61.73x
P/B
0.96x
EPS (TTM)
₹0.78
Book value / share
₹10.39
ROE
7.52%
ROCE
7.79%
ROA
5.99%
Debt / equity
0.06x
Dividend yield
0%
EBITDA margin
9.77%
52-week range
₹8 – ₹26.2

Ratios are computed from filed results and the last recorded price. Not investment advice.

Financial Performance

Mar 2026

In the year ended Mar 2026, Abate As Industries Ltd (ABATEAS) reported revenue of ₹159 crore, net profit of ₹12 crore and earnings per share of ₹0.78. That compares with revenue of ₹14 crore and net profit of ₹1 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.

In the quarter ended Mar 2026, revenue was ₹33.94 crore and net profit ₹2.93 crore (consolidated).

Consolidated annual results for Abate As Industries Ltd (ABATEAS), Mar 2025 to Mar 2026. Revenue and net profit in ₹ crore; EPS in ₹ per share.
MetricMar 2025Mar 2026
Revenue (₹ cr)14159
Net profit (₹ cr)112
EPS (₹)0.070.78
Compound annual growth for Abate As Industries Ltd (ABATEAS). Stock price CAGR is price return and excludes dividends.
Measure10Y5Y3Y1Y
Profit growth-87.61%-159.34%
Stock price CAGR24%29%1%-55%

Ownership Summary

Jun 2026

As of Jun 2026, promoters hold 32.42% of Abate As Industries Ltd (ABATEAS) (unchanged from the previous quarter). Market capitalisation was ₹157 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2001.

Largest disclosed public shareholders in Jun 2026: Abdul Karim Meerakutty Pazhariyi 14.3%, Shireen M T 14.17%, Fazil Chemmankuzhiyil 10.12%, LLP 9.36%. Only stakes above the 1% disclosure threshold are named in filings.

QuarterPromoterPledgedFIIDIIPublic
Jun 202632.42%---67.58%
Mar 202632.42%---67.58%
Dec 202527.56%---72.44%
Sep 202527.56%---72.44%
Jun 202527.56%---72.44%
Mar 202527.56%---72.44%
Dec 202431.87%---68.13%
Sep 202431.87%---68.13%
Every quarter since Mar 2001 Filing data, not investment advice.